Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder

被引:67
作者
Berent, Dominika [1 ]
Zboralski, Krzysztof [2 ]
Orzechowska, Agata [2 ]
Galecki, Piotr [2 ]
机构
[1] Babinski Mem Hosp, PL-91229 Lodz, Poland
[2] Med Univ Lodz, Dept Adult Psychiat, PL-91229 Lodz, Poland
关键词
Major depression; Thyroid hormones; Treatment; Outcome; RATING-SCALE; DEIODINASE; SERTRALINE;
D O I
10.1007/s11033-014-3097-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The clinical implications of thyroid hormones in depression have been studied extensively and still remains disputable. Supplementation of thyroid hormones is considered to augment and accelerate antidepressant treatment. Studies on the role of thyroid hormones in depression deliver contradictory results. Here we assess theirs impact on depression severity and final clinical outcome in patients with major depression. Thyrotropin, free thyroxine (FT4), and free triiodothyronine (FT3) concentrations were measured with automated quantitative enzyme immunoassay. Depression severity and final clinical outcome were rated with 17-itemic Hamilton Rating Scale for Depression [HDRS(17)] and Clinical Global Impression Scales for severity and for improvement (CGIs, CGIi). FT3 and FT4 concentrations were significantly positively correlated with clinical improvement evaluated with CGIi (R = 0.38, P = 0.012; R = 0.33, P = 0.034, respectively). There was a significant correlation between FT4 concentrations and depression severity assessed in HDRS(17) (R = 0.31, P = 0.047). Male patients presented significantly higher FT3 serum levels (Z = 2.34, P = 0.018) and significantly greater clinical improvement (Z = 2.36, P = 0.018) when compared to female patients. We conclude that free thyroid hormones concentrations are associated with depression severity and have an impact on final clinical outcome. It can be more efficient to augment and accelerate the treatment of major depressive disorder with triiodothyronine instead of levothyroxine because of individual differences in thyroid hormones metabolism.
引用
收藏
页码:2419 / 2425
页数:7
相关论文
共 32 条
[1]   Triiodothyronine augmentation in the treatment of refractory depression - A meta-analysis [J].
Aronson, R ;
Offman, HJ ;
Joffe, RT ;
Naylor, CD .
ARCHIVES OF GENERAL PSYCHIATRY, 1996, 53 (09) :842-848
[2]  
Bauer M, 2003, PHARMACOPSYCHIATRY, V36, pS215
[3]   Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders [J].
Bauer, M ;
Baur, H ;
Berghöfer, A ;
Ströhle, A ;
Hellweg, R ;
Müller-Oerlinghausen, B ;
Baumgartner, A .
JOURNAL OF AFFECTIVE DISORDERS, 2002, 68 (2-3) :285-294
[4]   The clinical significance of subclinical thyroid dysfunction [J].
Biondi, Bernadette ;
Cooper, David S. .
ENDOCRINE REVIEWS, 2008, 29 (01) :76-131
[5]   Thyroid disorders in mental patients [J].
Bunevicius, Robertas .
CURRENT OPINION IN PSYCHIATRY, 2009, 22 (04) :391-395
[6]  
Canaris GJ, 2000, ARCH INTERN, V160, P24
[7]   Combined treatment with sertraline and liothyronine in major depression - A randomized, double-blind, placebo-controlled trial [J].
Cooper-Kazaz, Rena ;
Apter, Jeffrey T. ;
Cohen, Revital ;
Karagichev, Leonid ;
Muhammed-Moussa, Said ;
Grupper, Daniel ;
Drori, Taly ;
Newman, Michael E. ;
Sackeim, Harold A. ;
Glaser, Benjamin ;
Lerer, Bernard .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (06) :679-688
[8]   Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine [J].
Cooper-Kazaz, Rena ;
van der Deure, Wendy M. ;
Medici, Marco ;
Visser, Theo J. ;
Alkelai, Ana ;
Glaser, Benjamin ;
Peeters, Robin P. ;
Lerer, Bernard .
JOURNAL OF AFFECTIVE DISORDERS, 2009, 116 (1-2) :113-116
[9]   Effects of Selective Serotonin Reuptake Inhibitors on Thyroid Function in Depressed Patients with Primary Hypothyroidism or Normal Thyroid Function [J].
de Carvalho, Gisah Amaral ;
Bahls, Saint-Clair ;
Boeving, Anke ;
Graf, Hans .
THYROID, 2009, 19 (07) :691-697
[10]   Evidence for a Dysregulated Immune System in the Etiology of Psychiatric Disorders [J].
Gibney, Sinead M. ;
Drexhage, Hemmo A. .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2013, 8 (04) :900-920